[Neuromuscular manifestations of HIV-1 and HTLV-I infections].
Hartung
H P
HP
Neurologische Klinik der Universität Düsseldorf.
Heininger
K
K
Toyka
K V
KV
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002211:Capsaicin / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D003711:Demyelinating Diseases / Q000188:drug therapy / Q000209:etiology; D015774:Ganciclovir; D015497:HIV-1; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D009135:Muscular Diseases / Q000188:drug therapy / Q000209:etiology; D009443:Neuritis / Q000188:drug therapy / Q000209:etiology; D009468:Neuromuscular Diseases / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D011115:Polyneuropathies / Q000188:drug therapy / Q000209:etiology; D015215:Zidovudine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D002220:Carbamazepine; D015215:Zidovudine; D015774:Ganciclovir; D002211:Capsaicin; D000212:Acyclovir
Neuromuskuläre Manifestationen der HIV-1- und HTLV-I-Infektionen.